Zur Kurzanzeige

2004-09-01Zeitschriftenartikel DOI: 10.25646/689
Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002
dc.contributor.authorTiemersma, Edine W.
dc.contributor.authorBronzwaer, Stef L.A.M.
dc.contributor.authorLyytikäinen, Outi
dc.contributor.authorDegener, John E.
dc.contributor.authorSchrijnemakers, Paul
dc.contributor.authorBruinsma, Nienke
dc.contributor.authorMonen, Jos
dc.contributor.authorWitte, Wolfgang
dc.contributor.authorGrundmann, Hajo
dc.date.accessioned2018-05-07T14:15:54Z
dc.date.available2018-05-07T14:15:54Z
dc.date.created2010-12-06
dc.date.issued2004-09-01none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/rev5HBnXSdPg/PDF/20MNU3nhGx8s.pdf
dc.identifier.urihttp://edoc.rki.de/176904/764
dc.description.abstractWe explored the variation in proportions of methicillin-resistant Staphylococcus aureus (MRSA) between and within countries participating in the European Antimicrobial Resistance Surveillance System and temporal trends in its occurrence. This system collects routine antimicrobial susceptibility tests for S. aureus. We examined data collected from January 1999 through December 2002 (50,759 isolates from 495 hospitals in 26 countries). MRSA prevalence varied almost 100-fold, from 40% in southern and western Europe. MRSA proportions significantly increased in Belgium, Germany, Ireland, the Netherlands, and the United Kingdom, and decreased in Slovenia. Within countries, MRSA proportions varied between hospitals with highest variance in countries with a prevalence of 5% to 20%. The observed trends should stimulate initiatives to control MRSA at national, regional, and hospital levels. The large differences between hospitals indicate that efforts may be most effective at regional and hospital levels.eng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionskrankheiten / Erreger
dc.subjectHumanseng
dc.subjectPrevalenceeng
dc.subjectPopulation Surveillanceeng
dc.subjectEurope/epidemiologyeng
dc.subjectQuality Assuranceeng
dc.subjectHealth Careeng
dc.subjectMethicillin Resistanceeng
dc.subjectStaphylococcus aureus/drug effectseng
dc.subjectStaphylococcal Infections/epidemiologyeng
dc.subjectStaphylococcal Infections/microbiologyeng
dc.subjectInternational Cooperationeng
dc.subject.ddc610 Medizin
dc.titleMethicillin-resistant Staphylococcus aureus in Europe, 1999–2002
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10011719
dc.identifier.doihttp://dx.doi.org/10.25646/689
local.edoc.container-titleEmerging Infectious Diseases
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://www.cdc.gov/ncidod/eid/vol10no9/04-0069.htm
local.edoc.container-publisher-nameCenters for Disease Control and Prevention
local.edoc.container-volume10
local.edoc.container-issue9
local.edoc.container-year2004

Zur Kurzanzeige